India Ranbaxy gets FDA nod for cyclobenzaprine HCL
MUMBAI, May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) has received approval from the U.S. Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets, the regulator's website showed.
The FDA has also granted tentative approval to Lupin Pharmaceuticals Inc, a unit of Lupin Ltd (LUPN.BO: Quote, Profile, Research), for ramipril capsules, used in treating cardiovascular disease and high blood pressure. (Reporting by Rina Chandran; Editing by John Mair)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
